Eden Biologics announces the new CEO Dr. Steve Lee

Eden Biologics Inc., a prominent worldwide biotechnology firm located in Hsinchu (Taiwan), Dr. Steve Lee, an established biotech executive with vast expertise and entrepreneurial leadership has been appointed as the company’s new CEO and director of its board, effective immediately.

A highly respected CEO and global business leader, Dr. Steve Lee has over 30 years of experience in biologics research and bioprocess development as well as business and strategic planning. He also has extensive experience in commercial manufacturing in a highly regulated environment, including emerging markets. As a biotech entrepreneur and leader of big biopharmaceutical businesses in the US and Asia, Dr. Lee has been instrumental in converting companies into high-performance organizations.

We are delighted to welcome Dr. Steve Lee as Eden Biologics‘ new CEO. A well-recognized and accomplished scientific leader, he joins Eden at a moment when the company is well-positioned for development and innovation.As a strategic leader with a proven track record of effective operational execution, Dr. Lee is in a great position to continue to grow Eden Biotech’s booming biologics development while keeping a laser-like focus on our mission to create cheap, high-quality biological medicines. I am thrilled to have him lead Eden and take advantage of any potential worldwide market prospects because of his essential commercial knowledge in the manufacture of both therapeutic biologics and innovative vaccines.”

BioGENEXUS, LLC’s former CEO and founder Dr. Lee pioneered disruptive innovation and breakthrough manufacturing technology platforms while delivering biotech consulting services to clients across the world before joining.It’s now time for him to contribute his significant biotech industry expertise, strong leadership and enthusiasm to Eden Biologics in the aim of growing Eden’s innovative, cost-effective biologics research platform and manufacturing partnerships in Asia and America.